🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT05750992
Recruiting Not applicable

Ultrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section

NCT05750992 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2023-04-10
Last updated
2026-01-06

Condition(s) studied

Cesarean SectionUltrasound Guided Transversus Abdominis Plane BlockSurgical Transversus Abdominis Plane BlockBupivacaineAcute Pain

Investigational drug(s) / intervention(s)

surgical TAP blockUS guided TAP block

surgical TAP block: performed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally by the surgeon.

US guided TAP block: performed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally.

Study summary

The aim of this study is to compare Surgical Transversus abdominis plane block and Ultrasound guided transversus abdominis plane block (TAPB) as a postoperative analgesic regimen in female patients undergoing elective cesarean delivery.

Eligibility

Sex
FEMALE
Min age
21 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Full term pregnant women * Older than 21 years of age * Had elective cesarean section with Pfannenstiel incision. Exclusion Criteria: * Patients with cesarean section using different surgical incision * History of addiction \[including opioids and benzodiazepines\] * Allergy to the anesthetic analgesia * Psychological disorders * Coagulopathies * Infection at the block injection site.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kohaf Cairo Egypt Recruiting

More Al-Azhar University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05750992 on ClinicalTrials.gov ↗ ← All trials in Egypt